Noom gets into compounded GLP-1s with a taper-off guarantee: It’s building a weight loss program around the idea that patients will eventually want to stop taking the medications. We explore the pros and cons.
FDA warns AbbVie for misleading TV ad ft. Serena Williams: Pharma marketers—particularly those who work with celebrities—ought to pay close attention to the regulator’s assertions.
The Surgeon General’s plan to protect kids, backed by state attorneys general, could change how platforms and advertisers engage users.
AI chatbots help busy healthcare providers communicate with patients: Consumers would rather engage with AI than wait on hold for a human. But many are concerned with the tech’s reliability and ability to protect their data.
Biden Administration’s final rules aim to boost mental healthcare parity law: But with no new enforcement mechanisms in place, we’re bearish on their ability to improve patients’ access to mental healthcare in a meaningful way.
Apple unveils new Apple Watch feature that detects sleep apnea: The timing of the feature’s unveiling could be the spark Apple needs to reignite its stagnating device business.
Ochsner expands its virtual weight management solution: The health system’s focus on selectively prescribing GLP-1s through affiliated physicians is a discerning financial move.
Global consumers are investing money to improve their health: There’s a market opportunity for brands and retailers across multiple sectors to reach consumers’ wallets via social media.
Senior-focused primary care orgs get patients to have more visits: While interesting, new findings from the Humana-led study should be taken with a grain of salt. The insurer has skin in the game with its CenterWell Senior Primary Care brand and clinics.
On today's podcast episode, we discuss how physicians are thinking about AI, the specific problems in healthcare that AI is trying to solve, and what it should never be used for in the space. Tune in to the discussion with host Marcus Johnson and analyst Rajiv Leventhal.
On today's podcast episode (part 1), we discuss why consumers are using GenAI to look up health information, how physicians feel about it, and how this stacks up against other health-related internet searches. Tune in to the discussion with our analyst Rajiv Leventhal.
On today's podcast episode (part 2), we discuss how doctors are using GenAI to deliver healthcare, how patients feel about it, and why you may climb into a large AI-driven box for your next primary care visit. Tune in to the discussion with our analyst Rajiv Leventhal.
On today's podcast episode, we discuss what happened when the first human ever received a brain implant from Neuralink, the other potential benefits of this technology outside of helping people with paralysis, and what the ultimate goal of Neuralink actually is. "In Other News," we talk about what happens now that ChatGPT has a memory and what to make of Gemini's rough start. Tune in to the discussion with our analysts Jacob Bourne and Gadjo Sevilla.
On today's podcast episode, we discuss how much Amazon's new shopping chatbot can move the needle, what Planet Fitness' out-of-home ad network looks like, becoming a digital mannequin to see what clothes look like on you, whether minutelong soap operas will catch on, who the smartest people in the world are, and more. Tune into the discussion with vice president of content Suzy Davidkhanian, analyst Evelyn Mitchell-Wolf, and vice president of Briefings Stephanie Taglianetti.
On today's podcast episode, our contestants compete in The Great Behind the Numbers Take Off, 2024 health trends edition, where they will try and cook up the most interesting predictions for the coming year. They'll discuss why healthcare is going to be a hyper-partisan issue in the 2024 US election campaigns; how that will affect how people think about and deal with their own healthcare going forward; and why the coming year will create unprecedented challenges for patients when it comes to affording care and treatment, leading them to explore other options for accessing and paying for care. Tune in to the discussion with our analysts Rajiv Leventhal and Lisa Phillips.
On today's podcast episode, we discuss how this year will look as Google's cookies fade away, the biggest threat to Google's search dominance, how many consumers are moving to ad-supported streaming, whether Apple can move the VR needle, Peloton's content hub on TikTok, the first person to ever complete Tetris, and more. Tune in to the discussion with our analysts Ross Benes, Evelyn Mitchell-Wolf, and Max Willens.
On today's podcast episode, we discuss how social networks could improve society, the NBA's plan to remake its TV deals, US consumers' feelings on shoppable ads, how many folks are "serial churners," how disruptive Sweetgreen's salad-making robot might be, a scientific breakthrough from a 14-year-old, and more. Tune in to the discussion with our forecasting writer Ethan Cramer-Flood, forecasting analyst Zach Goldner, and director of forecasting Oscar Orozco.
On today's podcast episode, we discuss what "Dr. ChatGPT" is most likely to help with, how close it is to replacing your physician, and why it might not be ready for the patient exam room just yet. "In Other News," we talk about the US government's efforts to bring down prescription drug costs and the prevalence of health-related misinformation on social media. Tune in to the discussion with our analysts Rajiv Leventhal and Lisa Phillips.
On today's episode, we discuss Gen Zers and healthcare: what the beginning of their journey looks like, social media as an entry point, and what they want from their experience. "In Other News," we talk about Amazon expanding its Amazon Clinic telehealth services to include video visits and how connected fitness is getting on post-pandemic. Tune in to the discussion with our analysts Rajiv Leventhal and Lisa Phillips.
On today's episode, we discuss the state of millennials' health, the most popular ways this generation engages with healthcare, and what digital health tools interest them the most. "In Other News," we talk about who's selling unapproved weight loss drugs, and how and why healthcare providers and Gen Z consumers are meeting on TikTok. Tune in to the discussion with our analysts Rajiv Leventhal and Lisa Phillips.